CJC-1295 No DAC + Ipamorelin 10MG

⚠️ PAYMENT METHOD: PayID or Bank Transfer Only

After checkout, you must complete payment manually.

PayID is instant and recommended.

Orders not paid are automatically cancelled.

CJC-1295 (No DAC) + Ipamorelin is a blended peptide formulation commonly referenced in preclinical and laboratory research examining growth hormone–related signalling pathways. The combination pairs a short-acting growth hormone–releasing hormone (GHRH) analogue with a selective growth hormone secretagogue, allowing researchers to study pulsatile GH release dynamics in controlled experimental models.

This product is supplied strictly for research and laboratory use only and is not intended for human or veterinary application.

Key Research Notes

• Frequently referenced in experimental models assessing synergistic interaction within growth hormone release pathways
• CJC-1295 (No DAC) is a short-acting GHRH analogue, while Ipamorelin is a selective GH secretagogue
• Blended formulation supplied in lyophilised form for stability and consistency in laboratory environments

Product Information

• Compound: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin (blend)
• Form: Lyophilised powder
• Kit Size: 10 mg blended research vial
• Purity: Independently tested (COA available)
• Handling: Reconstitution and storage should follow standard laboratory protocols

Quality & Testing

All Paragon compounds undergo third-party analytical testing to verify purity, identity, and consistency. Certificates of Analysis (COAs) are available for transparency and quality assurance.

Important Notice

This compound is sold exclusively for research purposes.
Not approved for human consumption, injection, or therapeutic use.
Purchasers must be 18 years or older and acknowledge responsibility for proper laboratory handling.